What risks could derail PBH's earnings growth trajectory?

Prestige Consumer Healthcare (PBH) faces several risks that could potentially derail its earnings growth trajectory: 1. **Global Economic Conditions**: PBH is monitoring the impact of global economic conditions, including supply chain constraints and inflation, on its operations and financial performance. These factors can lead to increased costs, reduced demand, and disruptions in the supply chain, which can negatively affect earnings growth. 2. **Supply Chain Issues**: The company has warned about the persistence of supply-chain issues in the first half of the fiscal year, which could dent revenue growth. These issues can lead to delays in product delivery, increased costs, and potential loss of sales due to stockouts. 3. **Cough & Cold Sales Downturn**: Despite strong demand and market presence in the GI products segment, the company has experienced a decline in sales in the Cough & Cold segment. This downturn can impact overall sales growth and earnings. 4. **International Segment and E-commerce Sales**: While the international segment and e-commerce sales have shown solid growth, any adverse changes in these markets or competitive landscape could affect future earnings growth. In summary, PBH's earnings growth trajectory could be derailed by global economic conditions, supply chain issues, cough & cold sales downturn, and international segment and e-commerce sales.